Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

  • This share is currently suspended. It was suspended at a price of 0.25
  • There is currently no data for TLY

Trading Update

14 Jan 2015 07:00

RNS Number : 0786C
Totally PLC
14 January 2015
 



14 January 2015

Totally plc

("Totally" or "the Company")

 

Trading update

 

The Board of Totally (AIM: TLY), the provider of a range of services to the healthcare sector, is today providing a post year end trading update.

The continued focus of Totally is on innovative solutions for the management of long-term health conditions and the growth of the business is being led by Wendy Lawrence, CEO. In the past year Totally Health Limited, the Company's wholly owned operating subsidiary, has made significant progress in a number of areas in developing and growing its business with the NHS and other healthcare providers. During 2014, Totally was appointed by 9 new clinical commissioning groups ("CCGs") to undertake clinical health coaching programmes focused on the management of long-term conditions and the pipeline for new contracts remains healthy. In particular, the contracts signed with Waltham Forest, Bedfordshire and Hartlepool and Stockton-on-Tees extended the services provided by Totally into Coronary Heart Disease, Diabetes and Chronic Heart Failure, which are new treatment areas, meaning that Totally now works in four of the UK's top five long-term conditions.

However, in the second half of the year the Company has experienced delays in the signing of new contracts and renewals with a small number of CCGs, a Commissioning Support Unit (CSU) and a specialist healthcare organisation, all of which were expected to contribute revenues in the year ended 31 December 2014. The Board of Totally is confident that these delayed contracts will be successfully executed and will contribute positively to the out-turn for the Company in 2015. Administrative expenses for the year ended 31 December 2014 are in line with current market expectations.

As a result of these contract delays revenue for the year ended 31 December 2014 will be below current market expectations, with net loss for the same period being greater than current market expectations.

During November 2014 and December 2014 the Company made a small profit and was cash generative. The Board of Totally is confident that the contract delays experienced by Totally will not impact on the cash position of the Company moving forward.

Given the continued renewals of existing contracts with CCGs and the pipeline of contracts in place for 2015 with CCGs, the NHS and other healthcare organisations, the Board of Totally remain confident of the prospects for the business for 2015. The Board of Totally believe that the board appointments made over recent months are contributing positively to the Company's corporate development activities and pipeline. The Company is currently exploring several corporate opportunities, which include acquisitions and strategic alliances.

 

Totally Plc / Totally Health Limited

 020 3077 2212

Wendy Lawrence, Chief Executive

Don Baladasan, Finance Director

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 020 3328 5656

Nick Naylor / Nick Athanas / Alex Brearley

Optiva Securities Limited (Joint Broker)

020 3137 1902

Christian Dennis / Jeremy King

Blytheweigh

020 7138 3203

Tim Blythe / Camilla Horsfall

 

Notes to Editors

Totally Health Ltd is focused on the provision of professional clinical health coaching which promotes and facilitates self care. Totally's services have been shown to reduce costs for Clinical Commissioning Groups by, for example, reducing unplanned admissions to hospitals and visits to Accident and Emergency Departments.

Totally currently operates contracts with NHS England and 9 Clinical Commissioning Groups across England. Shareholders should note that the National Health Service estimates that £7 out of every £10 spent in England on health and social care is supporting people diagnosed with a Long Term Condition.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVXLFFEFFBBBV
Date   Source Headline
7th Jul 20257:00 amRNSCancellation - Totally Plc
9th Jun 20257:00 amRNSAdministration and Director Resignations
6th Jun 20251:00 pmRNSIntention to Appoint Administrators and Suspension
6th Jun 20251:00 pmRNSSuspension - Totally plc
30th May 20252:25 pmRNSHolding(s) in Company
29th May 20252:10 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSUpdate on Strategic Review
2nd May 20257:00 amRNSHolding(s) in Company
1st May 20257:00 amRNSCommencement of Strategic Review
1st May 20257:00 amRNSTrading Update
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20253:35 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20253:15 pmRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
28th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSContract Renewals
26th Feb 20251:00 pmRNSHolding(s) in Company
25th Feb 20256:00 pmRNSHolding(s) in Company
25th Feb 202511:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSDirectorate Change
20th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20257:00 amRNSOutlook Update
13th Jan 20257:00 amRNSDirectorate Change
7th Jan 20254:15 pmRNSHolding(s) in Company
3rd Dec 20244:00 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSInterim Results
5th Nov 20245:00 pmRNSHolding(s) in Company
31st Oct 20247:00 amRNSUpdate on Banking Facility
17th Oct 20247:00 amRNSNotice of Interim Results & Investor Presentation
27th Sep 20245:45 pmRNSResult of AGM
27th Sep 20249:00 amRNSAGM Statement
27th Sep 20247:00 amRNSContract Win and Extension
20th Sep 20242:30 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20241:30 pmRNSPosting of Annual Report and Notice of AGM
4th Sep 20247:00 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSContract Wins
27th Aug 20246:16 pmRNSHolding(s) in Company
27th Aug 20246:13 pmRNSHolding(s) in Company
2nd Aug 20249:30 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSDirectorate Change
1st Aug 202410:45 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDirectorate Change
24th Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSContract extensions and win
22nd Jul 20243:30 pmRNSHolding(s) in Company
18th Jul 20247:00 amRNSNotice of Results
11th Jul 20247:00 amRNSContract extensions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.